Milestone Pharmaceuticals

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$-868
$-868
$0
Gross Profit
-26
-28
-1,400
-23
EBITDA
-9,701
-10,516
-13,342
-14,216
EBIT
-9,727
-10,544
-13,385
-14,239
Net Income
-9,363
-10,354
-13,611
-15,081
Net Change In Cash
0
-868
-868
0
Free Cash Flow
-5,953
-8,934
-9,251
-12,178
Cash
13,262
10,131
13,760
9,879
Basic Shares
66,165
50,155
33,483
42,973

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,000
$5,000
$15,000
$15,000
Gross Profit
402
5,000
15,000
-376
EBITDA
-60,812
-59,553
-42,980
-50,613
EBIT
-61,410
-59,642
-43,342
-50,989
Net Income
-59,685
-57,134
-42,633
-49,967
Net Change In Cash
1,000
5,000
15,000
15,000
Cost of Revenue
41,831
-47,508
Free Cash Flow
-46,536
-52,741
-33,224
-50,732
Cash
13,760
7,636
114,141
72,310
Basic Shares
42,955
42,450
41,833
29,344

Earnings Calls

Quarter EPS
2024-06-30
-$0.14
2024-03-31
-$0.21
2023-12-31
-$0.32
2023-09-30
-$0.35